Biomeme Revenue and Competitors

Location

$1.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biomeme's estimated annual revenue is currently $14.7M per year.(i)
  • Biomeme's estimated revenue per employee is $155,000
  • Biomeme's total funding is $1.4M.

Employee Data

  • Biomeme has 95 Employees.(i)
  • Biomeme grew their employee count by -26% last year.

Biomeme's People

NameTitleEmail/Phone
1
Co-Founder / Biology LeadReveal Email/Phone
2
Co-founder, EVP EngineeringReveal Email/Phone
3
Co-Founder / President and CEOReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Associate Director Project ManagmentReveal Email/Phone
6
Director ManufacturingReveal Email/Phone
7
Research DirectorReveal Email/Phone
8
Director Customer SuccessReveal Email/Phone
9
Product ManagerReveal Email/Phone
10
Electrical Engineering ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M204-6%N/AN/A
#2
$14M100-12%$27.2MN/A
#3
$13.4M55N/AN/AN/A
#4
$1M12N/AN/AN/A
#5
$3.5M43N/AN/AN/A
#6
$24.9M156N/AN/AN/A
#7
$132.3M1286-3%$503.1M$3B
#8
$3.3M28N/AN/AN/A
#9
$141.7M65311%$1.35BN/A
#10
$2.8M28N/AN/AN/A
#11
$76.3M436N/AN/AN/A
#12
$8.8M35N/AN/AN/A
#13
$1321M5263N/AN/AN/A
#14
$102.3M334N/AN/AN/A
Add Company

What Is Biomeme?

Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time PCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The cutting edge platform performs to the gold standard used by the world's most advanced central labs but requires no lab equipment or special experience to use.\r\n\r\nThe low-cost, user-friendly system enables mobile testing at the point-of-need for health care (mobile clinics, disease tracking, home use), agriculture (plant disease tracking, food safety), vector surveillance (Malaria, West Nile mosquitos), veterinary medicine, environmental monitoring (soil and water safety), and even education and citizen science.

keywords:Biotechnology, Medical Devices, Diagnostics, Mobile Health, Quantified Self

$1.4M

Total Funding

95

Number of Employees

$14.7M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biomeme News

2022-04-20 - In the Galápagos, training community scientists to monitor ...

The equipment, provided by the biotechnology company Biomeme, can be set up on a tabletop and doesn't require refrigeration or electricity.

2022-03-22 - Philadelphia's Best Real Estate Deals of 2021: Office winners ...

Biomeme Inc., a diagnostic startup behind a rapid Covid-19 test, signed a 10-year lease on 49,200 square feet for a new headquarters,...

2021-09-09 - Biomeme Appoints Ephraim Tsalik, MD, PhD as Chief Medical Officer

Ephraim Tsalik, Chief Medical Officer at Biomeme, Inc Our team is focused on developing revolutionary point-of-care technology to better diagnose and manage disease. Together with the Biomeme team, I will leverage my experience to deliver our precision medicine solutions throughout the healthcar ...

2021-08-26 - Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare

Predigen and Biomeme Host Response Test System (HR-BV) PHILADELPHIA (PRWEB) August 26, 2021 Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic company and emerging leader in precision medicine focu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.5M958%N/A
#2
$21.1M964%N/A
#3
$23.6M964%N/A
#4
$7.5M96N/AN/A
#5
$14.4M96-3%N/A